Evidence map›Paper›PMID 42369203›Full record

ArticleRespiratory medicine case reports2026

Subcutaneous apomorphine-induced pneumonitis: An uncommon pulmonary adverse event.

Enrique Barrueco-Otero, Vanesa Hidalgo-Sierra, Patricia Torres Piñero, Isabel González Fernández, Laura Gil Pintor, María Bartol Sánchez, María Jesús Corbi Cobo-Losey, Carlos Montilla, Miguel Ángel Hernández-Mezquita

Abstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Enrique Barrueco-OteroOutpatient follow-up, Primary Care Service, University Hospital of Salamanca, Spain.
Vanesa Hidalgo-SierraOutpatient follow-up, Primary Care Service, University Hospital of Salamanca, Spain.
Patricia Torres PiñeroPulmonology Service, University Hospital of Salamanca, Spain.
Isabel González FernándezInternal Medicine Service, University Hospital of Salamanca, Spain.
Laura Gil PintorPulmonology Service, University Hospital of Salamanca, Spain.
María Bartol SánchezPulmonology Service, University Hospital of Salamanca, Spain.
María Jesús Corbi Cobo-LoseyPulmonology Service, University Hospital of Salamanca, Spain.
Carlos MontillaUniversity Hospital of Salamanca and Department of Medicine, University of Salamanca (USAL), Spain.
Miguel Ángel Hernández-MezquitaPulmonology Service, University Hospital of Salamanca and Department of Medicine, University of Salamanca (USAL), Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Apomorphine is a potent dopaminergic agonist widely used in the management of motor fluctuations in advanced Parkinson's disease. Although generally well tolerated, rare pulmonary adverse drug reactions (ADRs) may occur. We report a case of probable apomorphine-induced pneumonitis associated with subcutaneous administration. Case presentation: A 62-year-old Caucasian male with multiple comorbidities presented to the emergency department with headache, non-productive cough, central chest pain, fever, and dyspnea over the past 48 hours Conclusion: The temporal relationship between apomorphine initiation and symptom onset, compatible clinical and radiological findings, extensive microbiological exclusion of infectious causes, and favorable response after drug withdrawal and corticosteroid therapy supported the diagnosis of probable apomorphine-induced pneumonitis.

Indexed as

Adverse drug reactionApomorphineParkinson's diseasePharmacovigilancePneumonitis

Identifiers

PMID42369203
PMCPMC13293733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.